1-Benzylbenzimidazoles: The discovery of a novel series of bradykinin B1 receptor antagonists
Graphical abstract
The design, synthesis, and structure–activity studies of a novel series of BK B1 receptor antagonists based on a 1-benzylbenzimidazole chemotype are described. A number of compounds, for example, 38g, with excellent affinity for the cynomolgus macaque and rat BK B1 receptor were discovered.
References and notes (17)
- et al.
Ann. Rep. Med. Chem.
(2003) - et al.
J. Pharmacol. Exp. Ther.
(2004) - et al.
J. Med. Chem.
(2007) - et al.
J. Med. Chem.
(2003)bA closely related analog of 3 (h BK1 Ki=13nM and MW=592) has a reported oral bioavailability in rat of 32% with... Clin. Exp. Pharmacol. Physiol.
(2001)Cardiovasc. Res.
(2002)et al.Pharmacol. Rev.
(1998)- et al.
Pharmacol. Rev.
(1980) Immunopharmacology
(1995)- et al.
Neuropharmacology
(1997)et al.Proc. Natl. Acad. Sci. U.S.A.
(2000)et al.Neuropharmacology
(2002)et al.J. Neurosci.
(2005)
Cited by (12)
Benzimidazole: An emerging scaffold for analgesic and anti-inflammatory agents
2014, European Journal of Medicinal ChemistryCitation Excerpt :But because of high molecular weight and poor oral bioavailability in rodents the phenethylbenzodiazepine moiety of 15 (Scheme 4) was replaced by benzimidazole core a low molecular weight surrogate, led to potent compound at both human and rat bradykinin B1 receptors with improved oral bioavailability. The 2-carboxamide group was important for the activity and a number of different linkers and amine groups like pyridine and piperidine moieties were studied but the combination of β-alanine linker and 2-imidazoline-5-aminopyridine group, however, led to the identification of compound 16 (Scheme 4) showing excellent potency with IC50 = 2 nM [43]. Similarly, Zischinsky et al. reported benzimidazole derivatives as small molecule bradykinin B1 receptor antagonist 17 (Scheme 4) with IC50 value 3500 nM.
Novel small molecule bradykinin B<inf>1</inf> receptor antagonists. Part 3: Hydroxyurea derivatives
2010, Bioorganic and Medicinal Chemistry LettersSulfonamido-aryl ethers as bradykinin B1 receptor antagonists
2009, Bioorganic and Medicinal Chemistry LettersPolypharmacology: Principles and methodologies
2022, Polypharmacology: Principles and MethodologiesKinin B1 receptors as a therapeutic target for inflammation
2018, Expert Opinion on Therapeutic Targets